Business Description
GenoFocus Inc
ISIN : KR7187420005
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.73 | |||||
Debt-to-EBITDA | 4.57 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 1.15 | |||||
Beneish M-Score | -2.25 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.8 | |||||
3-Year EPS without NRI Growth Rate | 9.6 | |||||
3-Year FCF Growth Rate | 30.9 | |||||
3-Year Book Growth Rate | -18.6 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.85 | |||||
9-Day RSI | 58.64 | |||||
14-Day RSI | 56.77 | |||||
6-1 Month Momentum % | 10.92 | |||||
12-1 Month Momentum % | -0.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.62 | |||||
Quick Ratio | 0.48 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 99.51 | |||||
Days Sales Outstanding | 67.34 | |||||
Days Payable | 12.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | 23.74 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 37.48 | |||||
Operating Margin % | -3.36 | |||||
Net Margin % | 3 | |||||
FCF Margin % | 3.56 | |||||
ROE % | 4.7 | |||||
ROA % | 1.18 | |||||
ROIC % | -0.91 | |||||
ROC (Joel Greenblatt) % | 17.7 | |||||
ROCE % | 23.37 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 84.31 | |||||
PE Ratio without NRI | 46.95 | |||||
PS Ratio | 2.84 | |||||
PB Ratio | 4.09 | |||||
Price-to-Tangible-Book | 4.49 | |||||
Price-to-Free-Cash-Flow | 77.49 | |||||
Price-to-Operating-Cash-Flow | 53.62 | |||||
EV-to-EBIT | 15.8 | |||||
EV-to-EBITDA | 14.9 | |||||
EV-to-Revenue | 4.02 | |||||
EV-to-FCF | 109.81 | |||||
Price-to-Graham-Number | 3.06 | |||||
Earnings Yield (Greenblatt) % | 6.33 | |||||
FCF Yield % | 1.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
GenoFocus Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 34,833.812 | ||
EPS (TTM) (â‚©) | 51 | ||
Beta | 0.48 | ||
Volatility % | 63.84 | ||
14-Day RSI | 56.77 | ||
14-Day ATR (â‚©) | 253.783592 | ||
20-Day SMA (â‚©) | 4152.75 | ||
12-1 Month Momentum % | -0.13 | ||
52-Week Range (â‚©) | 2880 - 5930 | ||
Shares Outstanding (Mil) | 24.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GenoFocus Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GenoFocus Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
GenoFocus Inc Frequently Asked Questions
What is GenoFocus Inc(XKRX:187420)'s stock price today?
When is next earnings date of GenoFocus Inc(XKRX:187420)?
Does GenoFocus Inc(XKRX:187420) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |